RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Clinical evaluation of a handheld self-treatment device for hair removal.

BACKGROUND AND OBJECTIVES: Laser- and light-based methods for hair removal, though effective, are expensive and may be associated with adverse effects. Our objective was to evaluate the efficacy and safety of a thermal, handheld self-treatment device (no!no! Thermicon, Radiancy Inc, Orangeburg, NY) for removing unwanted hair.

METHODS: Twelve of the 20 enrolled subjects underwent 6 supervised and 6 unsupervised self-treatments of their lower legs and umbilicus-bikini areas at twice-weekly intervals for 6 weeks. Follow-up visits were scheduled at 2, 6, and 12 weeks after the final treatment. Results were evaluated by pretreatment, post-treatment, and follow-up hair counts.

RESULTS: For legs, the median clearance percentages were 48% post-treatment and 43.5% at 12 weeks. For the umbilicus-bikini area, the median clearance percentage was 15% at 12 weeks.

CONCLUSIONS: The efficacy and safety of the no!no! Thermicon device for hair removal of the legs appear to be comparable to those of laser devices.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app